{"transactions":[{"id":1850208,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-20T16:36:52.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the options shall vest in full on the first anniversary of the grant date, subject to the reporting person's continuous service through such vesting date."}],"balance_after":13700,"derivative":{"exercise_price":1.04,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":13700},"source":{"system":"sec-edgar","filing":"0001062993-23-013831","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000106299323013831/form4.xml","form_type":"4"}},{"id":2055994,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-12T20:00:10.000Z","date":"2023-01-11","kind":"grant","acquired":true,"shares":33523,"price":0.44,"value":14750.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":375155,"source":{"system":"sec-edgar","filing":"0001415889-23-000919","document":"form4-01122023_080101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588923000919/form4-01122023_080101.xml","form_type":"4"}},{"id":2142994,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-05T21:26:59.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":58516,"price":0.3749,"value":21937.6484,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash\nfees."}],"balance_after":341632,"source":{"system":"sec-edgar","filing":"0001415889-22-010367","document":"form4-10052022_061048.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588922010367/form4-10052022_061048.xml","form_type":"4"}},{"id":2213229,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-06T16:30:36.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":50086,"price":0.438,"value":21937.668,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":283116,"source":{"system":"sec-edgar","filing":"0001415889-22-007483","document":"form4-07062022_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588922007483/form4-07062022_040701.xml","form_type":"4"}},{"id":2221598,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-27T16:30:56.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2022 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on June 23, 2023 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":26000,"derivative":{"exercise_price":0.4561,"exercise_date":"2023-06-23","expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001415889-22-006942","document":"form4-06272022_040631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588922006942/form4-06272022_040631.xml","form_type":"4"}},{"id":2234580,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-13T17:27:54.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.43,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001062993-22-014811","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000106299322014811/form4.xml","form_type":"4"}},{"id":2306110,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T17:04:56.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":41155,"price":0.535,"value":22017.925,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":233030,"source":{"system":"sec-edgar","filing":"0001415889-22-003846","document":"form4-04052022_020439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588922003846/form4-04052022_020439.xml","form_type":"4"}},{"id":2410403,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-07T16:09:11.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":12375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable monthly over 12 months beginning on March 4, 2022."}],"balance_after":12375,"derivative":{"exercise_price":10.4,"expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":12375},"source":{"system":"sec-edgar","filing":"0001104659-22-012782","document":"tm225605-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000110465922012782/tm225605-4_4seq1.xml","form_type":"4"}},{"id":2410402,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-07T16:09:11.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs vest in full on February 4, 2023, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":3312,"source":{"system":"sec-edgar","filing":"0001104659-22-012782","document":"tm225605-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000110465922012782/tm225605-4_4seq1.xml","form_type":"4"}},{"id":2445882,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T17:00:32.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":37062,"price":0.59,"value":21866.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":191875,"source":{"system":"sec-edgar","filing":"0001415889-22-000389","document":"form4-01052022_050102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588922000389/form4-01052022_050102.xml","form_type":"4"}},{"id":2553226,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T20:43:36.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":21229,"price":1.03,"value":21865.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to his election, under the issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":154813,"source":{"system":"sec-edgar","filing":"0001104659-21-122658","document":"tm2129259-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000110465921122658/tm2129259-1_4seq1.xml","form_type":"4"}},{"id":2674657,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T17:06:08.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2021 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on June 8, 2022 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":26000,"derivative":{"exercise_price":1.31,"exercise_date":"2022-06-08","expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001415889-21-002920","document":"form4-06102021_050650.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588921002920/form4-06102021_050650.xml","form_type":"4"}},{"id":2684733,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T16:10:49.000Z","date":"2021-06-01","kind":"purchase","acquired":true,"shares":85000,"price":1.19,"value":101150.0,"ownership":{"direct":true},"balance_after":133584,"source":{"system":"sec-edgar","filing":"0001415889-21-002782","document":"form4-06032021_040602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588921002782/form4-06032021_040602.xml","form_type":"4"}},{"id":2687238,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-02T17:01:24.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":68577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":68577,"derivative":{"exercise_price":1.74,"expiration_date":"2031-05-28","underlying":"Common Stock","underlying_shares":68577},"source":{"system":"sec-edgar","filing":"0001429560-21-000006","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000142956021000006/edgar.xml","form_type":"4"}},{"id":2759454,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T16:30:22.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":10939,"price":1.32,"value":14439.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":48584,"source":{"system":"sec-edgar","filing":"0001415889-21-001876","document":"form4-04052021_040403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588921001876/form4-04052021_040403.xml","form_type":"4"}},{"id":2904786,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-01-19T20:15:34.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest in 12 equal monthly installments, commencing on 1/31/21."}],"balance_after":16500,"derivative":{"exercise_price":12.6,"expiration_date":"2031-01-15","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001104659-21-005526","document":"tm213599d9_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000110465921005526/tm213599d9_4.xml","form_type":"4"}},{"id":2917387,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-06T16:37:03.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":3515,"price":4.02,"value":14130.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":37645,"source":{"system":"sec-edgar","filing":"0001179110-21-000328","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911021000328/edgar.xml","form_type":"4"}},{"id":3014443,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T16:05:41.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":5722,"price":2.25,"value":12874.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":34130,"source":{"system":"sec-edgar","filing":"0001179110-20-010219","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911020010219/edgar.xml","form_type":"4"}},{"id":3093798,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T20:55:41.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":7193,"price":1.79,"value":12875.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":28408,"source":{"system":"sec-edgar","filing":"0001179110-20-008004","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911020008004/edgar.xml","form_type":"4"}},{"id":3143937,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T18:55:22.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2020 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on May 12, 2021 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":11500,"derivative":{"exercise_price":1.97,"exercise_date":"2021-05-12","expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001179110-20-006346","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911020006346/edgar.xml","form_type":"4"}},{"id":3147586,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-15T17:17:05.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":64103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":64103,"derivative":{"exercise_price":1.05,"expiration_date":"2030-05-13","underlying":"Common Stock","underlying_shares":64103},"source":{"system":"sec-edgar","filing":"0001209191-20-029769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000120919120029769/doc4.xml","form_type":"4"}},{"id":3184891,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-03T17:16:54.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":10059,"price":1.28,"value":12875.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":21215,"source":{"system":"sec-edgar","filing":"0001179110-20-004657","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911020004657/edgar.xml","form_type":"4"}},{"id":3313751,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-01-10T16:52:27.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest in 12 equal monthly installments, commencing on 1/31/20."}],"balance_after":100000,"derivative":{"exercise_price":2.07,"expiration_date":"2030-01-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-20-003095","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000110465920003095/a4.xml","form_type":"4"}},{"id":3320066,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T16:09:29.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":7037,"price":1.85,"value":13018.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":11156,"source":{"system":"sec-edgar","filing":"0001179110-20-000287","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911020000287/edgar.xml","form_type":"4"}},{"id":3401907,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T20:56:11.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":4119,"price":2.67,"value":10997.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":4119,"source":{"system":"sec-edgar","filing":"0001104659-19-052802","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000110465919052802/a4.xml","form_type":"4"}},{"id":3499500,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T16:04:26.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2019 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on June 4, 2020 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":11500,"derivative":{"exercise_price":2.57,"exercise_date":"2020-06-04","expiration_date":"2029-06-04","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001179110-19-007276","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911019007276/edgar.xml","form_type":"4"}},{"id":3524254,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-16T17:30:29.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.34,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-030517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000120919119030517/doc4.xml","form_type":"4"}},{"id":3558883,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-10T17:38:30.000Z","date":"2019-04-08","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted under the Issuer's 2013 Stock Incentive Plan. The option vests and becomes exercisable over a three-year period commencing on April 8, 2019. Thirty-three percent (33%) of the underlying shares vest and become exercisable on April 8, 2020 (first anniversary of the date of grant) with the balance of the underlying shares vesting in eight equal quarterly installments over the remaining two years of the three-year period, subject to continued service with the Issuer. The option automatically becomes exercisable in full upon the occurrence of a change in control of the Issuer."}],"balance_after":23000,"derivative":{"exercise_price":2.66,"expiration_date":"2029-04-08","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001179110-19-004899","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911019004899/edgar.xml","form_type":"4"}},{"id":3626937,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-02-28T18:59:32.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"5,833 options to purchase shares of common stock vest immediately on 2/26/19.  The remainder vest in 10 equal monthly installments commencing 3/1/19."}],"balance_after":35000,"derivative":{"exercise_price":3.96,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-19-011639","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000110465919011639/a4.xml","form_type":"4"}},{"id":3855284,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T16:05:26.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":12669,"price":137,"value":1735653.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"shares","element":"transactionShares","label":"F3","text":"The amount reported represents the number of restricted stock units cancelled in connection with the Tender Offer by Roche and converted into the right to receive an amount in cash equal to the product of (1) the offer price of $137 per share multiplied by (2) the number of shares represented by such restricted stock units, without interest and less any required withholding taxes. The restricted stock units were granted on October 26, 2016 and vest in three annual installments or immediately upon a change-of-control of the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-044922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000120919118044922/doc4.xml","form_type":"4"}},{"id":3855283,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T16:05:26.000Z","date":"2018-07-31","kind":"other","acquired":false,"shares":12120,"price":137,"value":1660440.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Foundation Medicine, Inc., a Delaware corporation (the \"Company\") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the \"Merger Agreement\"), with Roche Holdings, Inc., a Delaware corporation (\"Parent\" or \"Roche\"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the \"Tender Offer\") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company."},{"field":"shares","element":"transactionShares","label":"F2","text":"The amount reported represents the number of shares sold by the reporting person in connection with the Tender Offer by Roche."}],"balance_after":12669,"source":{"system":"sec-edgar","filing":"0001209191-18-044922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000120919118044922/doc4.xml","form_type":"4"}},{"id":3928784,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-17T17:09:21.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.84,"expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-18-031033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000120919118031033/doc4.xml","form_type":"4"}},{"id":4138152,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-12-08T16:05:43.000Z","date":"2017-12-06","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest in 12 equal monthly installments commencing 1/1/18."}],"balance_after":35000,"derivative":{"exercise_price":6.19,"expiration_date":"2027-12-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-17-072518","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000110465917072518/a4.xml","form_type":"4"}},{"id":4274715,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-22T16:05:28.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":5786,"price":40.05,"value":231729.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted by the Issuer pursuant to its 2013 Stock Option and Incentive Plan and the Issuer's Non-Employee Director Compensation Policy. The restricted stock units vest on the earlier of June 20, 2018 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board of Directors, or immediately upon the death or disability of the director or upon a change-of-control of the Issuer."}],"balance_after":24789,"source":{"system":"sec-edgar","filing":"0001209191-17-041330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000120919117041330/doc4.xml","form_type":"4"}},{"id":4291448,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-06T16:41:56.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":3.08,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-038137","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000120919117038137/doc4.xml","form_type":"4"}},{"id":4311159,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-22T19:30:28.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":20000,"price":0.49,"value":9800.0,"ownership":{"direct":true},"balance_after":105000,"derivative":{"exercise_price":0.49,"exercise_date":"2018-05-18","expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-17-009785","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774917009785/rdgdoc.xml","form_type":"4"}},{"id":4499171,"issuer":{"id":154249,"kind":"organization","name":"MELINTA THERAPEUTICS, INC. /NEW/","symbol":"MLNT"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-05T21:56:30.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests on the following schedule: 1/12th of the shares vest monthly at the end of each month over 12 months, beginning after 01/01/2017."}],"balance_after":15000,"derivative":{"exercise_price":3,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-002494","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000120919117002494/doc4.xml","form_type":"4"}},{"id":4573043,"issuer":{"id":164565,"kind":"organization","name":"Foundation Medicine, Inc.","symbol":"FMI"},"owners":[{"id":112138,"kind":"person","name":"DOUGHERTY MICHAEL R","position":1,"cik":"0001033516","reported_name":"DOUGHERTY MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-28T16:10:26.000Z","date":"2016-10-26","kind":"grant","acquired":true,"shares":19003,"price":23.55,"value":447520.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted by the Issuer pursuant to its 2013 Stock Option and Incentive Plan and the Issuer's Non-Employee Director Compensation Policy upon the reporting person's election to the Board of Directors. The restricted stock units shall vest in three substantially equal annual installments during the three years following the grant date, subject to the director's continued service on the Board of Directors, or immediately upon the death or disability of the director or upon a change-of-control of the Issuer."}],"balance_after":19003,"source":{"system":"sec-edgar","filing":"0001209191-16-147287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033516/000120919116147287/doc4.xml","form_type":"4"}}]}